#HealthcareInnovation #CancerTreatment #Pediatrictreatment

Memorial Sloan Kettering Cancer Center’s Minimally Invasive Approach to Pediatric Brain and Spine Tumor Care

Author(s): MedEdge MEA

Every year, children across the Gulf are treated for headaches, nausheaea or clumsy walking, symptoms so ordinary they rarely raise alarm. But sometimes these signs point to something far more serious. In this exclusive conversation, Dr Andrew Kobets, pediatric neurosurgeon at Memorial Sloan Kettering Cancer Center (MSK), explains how minimally invasive techniques, intraoperative MRI and a family-centred approach are transforming outcomes for children facing brain and spine tumors, and when it’s time to seek a specialist opinion.

Can you share what recovery and rehabilitation typically look like for a young patient after a complex brain and spine tumor resection?

Read the full article

Related Articles

View All
What do you know about Samsung’s new Health Software Development Kit Suite? MedEdge MEA

Samsung Electronics introduced a new Samsung Health Software Development Kit (SDK) Suite. Designed to better support developers and researchers in creating innovative hea...

Read More
BD Completes Acquisition of Critical Care from Edwards Lifesciences MedEdge MEA

BD announced it has completed the acquisition of Edwards Lifesciences’ Critical Care product group, which will be renamed as BD Advanced Patient Monitoring. BD Advance...

Read More
Women in Finland to benefit from early detection of osteoporosis Infomedix International

Public mammography screening provider in Finland mobilizes against osteoporosis The Finnish mammography provider Suomen Radiologikeskus Oy has signed an agreement with...

Read More
What’s new in Apple’s health features for billions? MedEdge MEA

Apple unveiled breakthrough sleep and hearing health features coming to the Apple Watch and AirPods Pro 2 that further deliver on Apple’s commitment to health with experi...

Read More
EU Approves TEPKINLY® for Relapsed/Refractory Follicular Lymphoma MedEdge MEA

AbbVie recently announced that the European Commission (EC) has granted conditional marketing authorization for TEPKINLY® (epcoritamab) as a monotherapy for the treatment...

Read More
New diagnostic technique improves breast cancer screening Infomedix International

Flexible coils for magnetic resonance imaging are being designed to search for breast cancer faster and with less disadvantages. In a project funded by the Austrian Scien...

Read More
Pfizer Launches Digital Hub for Simplified Healthcare Access MedEdge MEA

Pfizer introduced PfizerForAll, a user-friendly digital platform designed to make access to healthcare and managing health and wellness more seamless for people across th...

Read More
Artificial Intelligence: A Tool At The Service Of Big Data Infomedix International

From the high tech to the medical sector, AI is showing all its resources, opening the doors to many global innovations. In a rapidly changing world, modern society is...

Read More
LIFEPAK 35: What do you know about this new Device? MedEdge MEA

Stryker announced the launch of LIFEPAK 35 monitor/defibrillator, the latest product in the monitor/defibrillator space, offering advanced technology and built on an intu...

Read More
Menu
Categories
How does it work